Telemetry Investments’s Rigel Pharmaceuticals RIGL Stock Holding History

Telemetry Investments’s Portfolio RIGL Stock Details RIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	$484K	Buy	32,250 +12,250	+61%	+$184K	0.76%	29
2022 Q3	$236K	Sell	20,000 -3,000	-13%	-$35.4K	0.3%	76
2022 Q2	$260K	Buy	23,000 +9,500	+70%	+$107K	0.31%	88
2022 Q1	$404K	Sell	13,500 -5,500	-29%	-$165K	0.64%	58
2021 Q4	$504K	Buy	19,000 +6,750	+55%	+$179K	0.65%	51
2021 Q3	$445K	Buy	12,250 +4,250	+53%	+$154K	0.6%	55
2021 Q2	$347K	Sell	8,000 -1,000	-11%	-$43.4K	0.48%	68
2021 Q1	$308K	Sell	9,000 -1,601	-15%	-$54.8K	0.35%	93
2020 Q4	$371K	Sell	10,601 -21,899	-67%	-$766K	0.63%	53
2020 Q3	$780K	Buy	32,500 +9,950	+44%	+$239K	1.69%	23
2020 Q2	$413K	Hold	22,550	–	–	1.12%	34
2020 Q1	$352K	Hold	22,550	–	–	1.23%	29
2019 Q4	$483K	Sell	22,550 -200	-0.9%	-$4.28K	1.61%	20
2019 Q3	$425K	Sell	22,750 -650	-3%	-$12.1K	1.23%	20
2019 Q2	$611K	Sell	23,400 -6,600	-22%	-$172K	0.47%	24
2019 Q1	$771K	Buy	30,000 +4,000	+15%	+$103K	0.39%	19
2018 Q4	$598K	Buy	26,000 +13,900	+115%	+$320K	0.38%	37
2018 Q3	$388K	Sell	12,100 -5,900	-33%	-$189K	0.18%	40
2018 Q2	$509K	Buy	18,000 +5,500	+44%	+$156K	0.19%	38
2018 Q1	$442K	Sell	12,500 -11,490	-48%	-$406K	0.17%	52
2017 Q4	$931K	Buy	23,990 +3,990	+20%	+$155K	0.35%	24
2017 Q3	$508K	Sell	20,000 -2,000	-9%	-$50.8K	0.18%	48
2017 Q2	$601K	Buy	22,000 +5,000	+29%	+$137K	0.28%	43
2017 Q1	$563K	Buy	17,000 +1,831	+12%	+$60.6K	0.25%	43
2016 Q4	$361K	Buy	15,169 +6,269	+70%	+$149K	0.2%	49
2016 Q3	$327K	Buy	8,900 +400	+5%	+$14.7K	0.21%	52
2016 Q2	$190K	Sell	8,500 -11,500	-58%	-$257K	0.1%	84
2016 Q1	$416K	Sell	20,000 -5,000	-20%	-$104K	0.12%	54
2015 Q4	$758K	Hold	25,000	–	–	0.26%	50
2015 Q3	$618K	Hold	25,000	–	–	0.26%	71
2015 Q2	$802K	Buy	25,000 +5,000	+25%	+$160K	0.36%	50
2015 Q1	$714K	Sell	20,000 -10,000	-33%	-$357K	0.39%	45
2014 Q4	$681K	Buy	+30,000	New	+$681K	0.42%	48